<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="ribavirin/PMC7114304/results/search/drugs/results.xml">
  <result pre="recruited by the GTase, transfers the methyl group from S-adenosyl-" exact="l-methionine" post="(AdoMet) to the cap guanine to form the cap-0"/>
  <result pre="PPi (II) PPPi (III) 6-chloropurine-ribose-5′-triphosphate. GTase inhibitors: (I) foscarnet (II)" exact="ribavirin" post="triphosphate. MTase inhibitors: (I) sinefungin (II) dAPPMA 2′-O MTase"/>
  <result pre="GTase inhibitors: (I) foscarnet (II) ribavirin triphosphate. MTase inhibitors: (I)" exact="sinefungin" post="(II) dAPPMA 2′-O MTase inhibitors: (III) aurintricaboxylic acid (IV)"/>
  <result pre="ribose 2′-OH position by 2′-O MTase (see Fig. 1). S-adenosyl-" exact="l-methionine" post="(SAM) is the methyl donor for both the N-7"/>
  <result pre="capping started in the dsDNA Poxviridae field. A SAM analogue," exact="sinefungin" post="(Fig. 6, MTase inhibitor I), was reported as the"/>
  <result pre="MTase activity was shown to be inhibited by the GTP-analogue" exact="ribavirin" post="triphosphate (Benarroch et al., 2004a), sinefungin, and SAH (Selisko"/>
  <result pre="antiviral therapy or prevention: a monoclonal antibody (Palivizumab, Synagis) and" exact="ribavirin" post="(Empey et al., 2010, Vigant and Lee, 2011). The"/>
  <result pre="of PRNTase inhibitors, but the precise mechanism of action of" exact="ribavirin" post="(i.e., capping, error catastrophe, IMP dehydrogenase, or else (Leyssen"/>
  <result pre="al., 2003). In the case of alphaviruses, resistance mutants to" exact="ribavirin" post="were mapped into the GTase domain of the nsP1"/>
  <result pre="protein (Scheidel et al., 1987, Scheidel and Stollar, 1991) suggesting" exact="ribavirin" post="interferes with the GTase activity. Nevertheless, the ribavirin action"/>
  <result pre="1991) suggesting ribavirin interferes with the GTase activity. Nevertheless, the" exact="ribavirin" post="action mode remains controversial. Ribavirin also reduces the intracellular"/>
  <result pre="The same group extended the family of interesting compounds with" exact="thalidomide" post="derivatives, active through their 3,4-dihydroxyphenethyl moieties, and later with"/>
  <result pre="inhibition of the NS5 dengue virus mRNA 2′-O-methyltransferase domain by" exact="ribavirin" post="5′-triphosphateJ. Biol. Chem.2792004356383564315152003 BenarrochD.SeliskoB.LocatelliG.A.MagaG.RometteJ.-L.CanardB.The RNA helicase, nucleotide 5′-triphosphatase, and"/>
  <result pre="as multisubstrate adductsJ. Pharm. Sci.7519861421453958922 BougieI.BisaillonM.The broad spectrum antiviral nucleoside" exact="ribavirin" post="as a substrate for a viral RNA capping enzymeJ."/>
  <result pre="as a targetAntiviral Res.8020089410118674567 LeyssenP.BalzariniJ.De ClercqE.NeytsJ.The predominant mechanism by which" exact="ribavirin" post="exerts its antiviral activity in vitro against flaviviruses and"/>
  <result pre="IMP dehydrogenaseJ. Virol.7920051943194715650220 LeyssenP.De ClercqE.NeytsJ.The anti-yellow fever virus activity of" exact="ribavirin" post="is independent of error-prone replicationMol Pharmacol6920061461146716421290 LiY.I.ChenY.J.HsuY.H.MengM.Characterization of the"/>
  <result pre="polymeraseJ. Virol.792005131051311516189012 LivonesiM.C.De SousaR.L.BadraS.J.FigueiredoL.T.In vitro and in vivo studies of" exact="ribavirin" post="action on Brazilian OrthobunyavirusAm. J. Trop. Med. Hyg.7520061011101617124004 LugariA.BetziS.DecrolyE.BonnaudE.HermantA.GuillemotJ.-C.DebarnotC.BorgJ.-P.BouvetM.CanardB.MorelliX.LecineP.Molecular"/>
  <result pre="of GTP pool is not the predominant mechanism by which" exact="ribavirin" post="exerts its antiviral effect on Lassa virusAntiviral Res.912011899321616094 PlotchS.J.BouloyM.KrugR.M.Transfer"/>
  <result pre="for viral cap-dependent transcriptionPLoS Pathog.692010e100110120862319 ScheidelL.M.DurbinR.K.StollarV.Sindbis virus mutants resistant to" exact="mycophenolic acid" post="and ribavirinVirology1581987173033882 ScheidelL.M.StollarV.Mutations that confer resistance to mycophenolic acid"/>
  <result pre="to mycophenolic acid and ribavirinVirology1581987173033882 ScheidelL.M.StollarV.Mutations that confer resistance to" exact="mycophenolic acid" post="and ribavirin on Sindbis virus map to the nonstructural"/>
  <result pre="and ribavirinVirology1581987173033882 ScheidelL.M.StollarV.Mutations that confer resistance to mycophenolic acid and" exact="ribavirin" post="on Sindbis virus map to the nonstructural protein nsP1Virology18119914904991826574"/>
  <result pre="of viruses by cytoplasmic sensorsCurr. Opin. Immunol.222010414720061127 ZhouS.LiuR.BaroudyB.M.MalcolmB.A.ReyesG.R.The effect of" exact="ribavirin" post="and IMPDH inhibitors on hepatitis C virus subgenomic replicon"/>
 </snippets>
</snippetsTree>
